Arryst Biosciences offers informative biotech applications directly to consumers. Its flagship product, a highly accurate DNA gender test, is recognized worldwide. The company has recently bundled its gender testing technologies with a pregnancy test kit, designed for women who are trying to get pregnant and want to know the sex of the unborn child soon after they become pregnant.
Arryst Biosciences, Inc. is a leader in the newly emerging industry of direct-to-consumer genetic testing services. The Company offers a growing line of products, enabling consumers to seek an affordable over-the-counter test which allows them to plan ahead, prepare for life changing events, and address specific lifestyle choices. These DNA tests are based on individual’s genetic profile and provide information on how the consumer can adjust lifestyle to a particular issue; whether it involves how to plan for a newborn baby boy or girl, or how altering caffeine or alcohol consumption might mitigate health risks.
The Company markets its first product to a global market. The PINK or BLUE Early Gender Test is a ‘first of its kind’ test. The product is poised for a position as an over-the-counter pregnancy test with optional gender detection kit, for women trying to get pregnant. It enables the mother-to-be to determine the sex of the unborn child as early as seven weeks, post-conception. Until recently, expectant mothers usually waited at least five months into their pregnancy before they could rely on an ultrasound to ascertain the gender of their child. In addition, ultrasounds are only about 80% accurate and often must be repeated multiple times in order to confidently determine the child’s gender. The revolutionary PINK or BLUE® Early DNA Gender Test is dependent on fetal DNA found in the mother's blood. It permits much earlier detection than an ultrasound, and enables sample collection in the privacy of one’s own home. Neither a visit to the physician nor a physician’s prescription is required for testing in most areas.
The PINK or BLUE Early DNA Gender Test is the first of a continuing series of affordable and accessible genetic tests designed by Arryst Biosciences, Inc. to assist consumers with enhancing the quality of their lives by utilizing recent genetic discoveries.